BioLife Plasma Services, L.P.

Form 483 issued April 22, 2026 · Las Vegas, Nevada

Inspection
Apr 21 – Apr 22, 2026
Investigator
Paul M. Chefor
Observations
1
Pages
3
FEI number
3025527098

In short: On April 22, 2026, FDA issued a Form 483 with 1 observation to BioLife Plasma Services, L.P. in Las Vegas, Nevada (FEI 3025527098) after an inspection that ran Apr 21 – Apr 22, 2026. The investigator was Paul M. Chefor. Most observations concern biologics CGMP; the most-cited regulation is 21 CFR 606.60 (equipment).

At a glance

1 of 1 observations on this 483 concern biologics cgmp.

Biologics CGMP1

Most cited: 21 CFR 606.60(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Failure to maintain equipment used in the collection of blood and blood products in a clean…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at BioLife Plasma Services, L.P.?

FDA listed 1 observation on this Form 483, mostly about biologics CGMP. The most-cited regulation is 21 CFR 606.60 (equipment). The opening words of each observation are shown on this page.

Who inspected BioLife Plasma Services, L.P.?

Paul M. Chefor is named on this Form 483, for the inspection of Apr 21 – Apr 22, 2026. Each investigator has a profile showing what they cite most.

When was BioLife Plasma Services, L.P. inspected by FDA?

The inspection ran Apr 21 – Apr 22, 2026, and the Form 483 is dated April 22, 2026.

How do I get the full Form 483 for BioLife Plasma Services, L.P.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free